7070 J . Org. Chem., Vol. 66, No. 21, 2001
Hakimelahi et al.
Sta n d a r d P r oced u r e for P r ep a r a tion of 5-Su bstitu ted -
3,4-d ia lk oxyfu r a n s 3a -c. To a solution of butenolides 2a -c
(1.0 mmol) in toluene (17.0 mL) was added diisobutylalumi-
num hydride at -78 °C under argon. After stirring for 1.0 h
at the same temperature, phosphate buffer (1.0 M, pH 7.2, 20
mL) solution was added. The organic layer was washed with
water (20 mL), dried (MgSO4), filtered, and concentrated under
reduced pressure. The residue was purified by use of column
chromatography (CH2Cl2 as eluant) to give the corresponding
furans 3a -c in about 82% yield. For 3a : 1H NMR (CDCl3) δ
3.73 (dd, J ) 8.00, 6.02 Hz, 1H, HC(7)), 3.84 (dd, J ) 8.00,
6.02 Hz, 1H, HC(7)), 4.79 (dd, J ) 6.02, 6.02 Hz, 1H, H-C(6)),
4.88 (s, 2H, OCH2O), 4.95 (d, J ) 15.60 Hz, 2H, H2COC(4)),
5.04 (s, 2H, H2COC(3)), 6.92 (s, 1H, H-C(2)), 7.30-7.37 (m,
10H, 2C6H5); 13C NMR (CDCl3) δ 66.38, 68.33, 72.98, 75.09,
95.39, 124.10, 127.36, 128.15, 128.25, 128.34, 128.54, 136.30,
136.70, 137.80, 142.99; UV (EtOH): λmax 269 (ꢀ 19030), 275 (ꢀ
18500), 298 (ꢀ 17300); CIMS m/z: 353 (M+ + 1), 352 (M+). Anal.
Calcd for C21H20O5: C, 71.58; H, 5.72. Found: C, 71.55; H,
5.74. For 3b: 1H NMR (CDCl3) δ 1.40 (s, 3H, CCH3), 1.46 (s,
3H, CCH3), 3.69 (s, 3H, OCH3), 3.83 (s, 3H, OCH3), 4.04 (dd,
J ) 7.00, 5.50 Hz, 1H, HC(7)), 4.11 (dd, J ) 7.00, 5.50 Hz, 1H,
HC(7)), 5.07 (dd, J ) 5.50, 5.50 Hz, 1H, H-C(6)), 6.91 (s, 1H,
H-C(2)); 13C NMR (CDCl3) δ 25.90, 26.13, 58.11, 61.21, 66.13,
68.94, 109.43, 122.74, 136.31, 138.24, 144.28; UV (EtOH): λmax
267 (ꢀ 18330), 274 (ꢀ 17410), 296 (ꢀ 18400); CIMS m/z: 229
(M+ + 1), 228 (M+). Anal. Calcd for C11H16O5: C, 57.89; H,
7.07. Found: C, 57.91; H, 7.12. For 3c: 1H NMR (CDCl3) δ
1.28 (s, 3H, CCH3), 1.35 (s, 3H, CCH3), 3.68 (s, 3H, OCH3),
3.70 (s, 3H, OCH3), 3.72 (dd, J ) 7.00, 5.45 Hz, 1H, HC(7)),
3.83 (dd, J ) 7.00, 5.45 Hz, 1H, HC(7)), 4.78 (dd, J ) 5.45,
5.45 Hz, 1H, H-C(6)), 4.73 (s, 2H, OCH2), 4.89 (s, 2H, OCH2),
6.86 (s, 1H, H-C(2)), 6.96 (AB, 4H, C6H4), 7.02 (AB, 4H, C6H4);
13C NMR (CDCl3) δ 25.83, 26.10, 55.12, 66.08, 68.72, 72.70,
74.70, 109.23, 113.64, 113.85, 124.09, 128.47, 128.95, 129.96,
130.22, 136.59, 137.39, 142.96, 159.55; UV (EtOH): λmax 270
Vero cells by furans 3a -c, butenolides 2a -c, rose bengal,
anthralin, and 8-MOP were carried out20 in the presence
of oxygen and solar light. The control cell lines received
the same amount of oxygen. Toxicity of the tested
compounds is expressed as the cytotoxic concentration
required to reduce normal cell growth by 50% (CC50).
Results are summarized in Table 1.
Anthralin generates superoxide anion, a highly toxic
species;5,6 yet furans 3a -c did not form superoxide in the
photooxidation process. Thus, furans 3a -c were found
to be much less toxic than anthralin. As such, the second
oxygen atom lost after ring opening of the endoperoxide
(cf. step 5 f 6) did not outweigh the benefit of not forming
superoxide. On the other hand, oxygen-dependent photo-
degradation of 8-MOP will produce furocoumarin deriva-
tives, which can react with membrane components,
causing irreversible damage to the cell.2c As a result,
8-MOP exhibited higher toxicity than furans 3a -c. Rose
bengal as a sensitizer converted 3O2 to 1O2, which
damaged the cells (Table 1). Under solar light, furans
3
3a -c also converted O2 to 1O2; yet consumption of which
by the furans produced nontoxic butenolides 2a -c.
Con clu sion s
3,4-Dialkoxy-5-alkylfurans 3a -d were developed as
novel oxygen scavengers, yet they did not produce
noxious superoxide. In the presence of UV- or sunlight
and air, photooxygenation of 3a -d proceeded through an
unprecedented pathway at room temperature to give
ascorbic acid 1 or its derivatives 2a -d in good to excellent
yields. Newly synthesized furans 3a -c were found to
be much less toxic than anthralin toward various cell
lines. These properties may prove to be of great potential
to the development of furans 3a -c as antipsoriasis
therapeutics.
(ꢀ 21000), 278 (ꢀ 19490), 297 (ꢀ 18550); CIMS m/z: 441 (M+
+
1), 440 (M+). Anal. Calcd for C25H28O7: C, 68.17; H, 6.41.
Found: C, 68.20; H, 6.51.
2-Deu ter io-3,4-d im eth oxy-6,7-isop r op ylid en -5-ylfu r a n
(3d ). A solution of 3b (114 mg, 0.491 mmol) in a mixture of
CDCl3 (1.6 mL) and D2O (1.6 mL) was irradiated with UV light
by use of a medium-pressure mercury lamp (450 W, λ > 250
nm) equipped with a Pyrex glass filter at room temperature
under argon for 5 h. The solution contained >95% of 3d as
Exp er im en ta l Section
Gen er a l. For anhydrous reactions, glassware was dried
overnight in an oven at 120 °C and cooled in a desiccator over
anhydrous CaSO4 or silica gel. Reagents were purchased from
Fluka Chemical Co. and used as is. Solvents, including dry
ether and tetrahydrofuran (THF), were obtained by distillation
from the sodium ketyl of benzophenone under nitrogen. Other
solvents, including chloroform, dichloromethane, ethyl acetate,
and hexanes were distilled over CaH2 under nitrogen. Absolute
methanol and ethanol were purchased from Merck and used
as received.
Melting points were obtained with a Bu¨chi 510 melting point
apparatus. Infrared (IR) spectra were recorded on a Perkin-
Elmer Paragon 1000 Fourier Transform spectrophotometer.
Carbon-13 NMR and proton NMR spectra were obtained on a
Varian XL-300 (300 MHz) spectrometer. Mass spectra were
carried out on a VG 70-250 S mass spectrometer. Photolytic
experiments were carried out by use of a 450-watt medium-
pressure mercury Canrad-Hanovia lamp with a Pyrex filter.
A sunlight lamp was obtained from Surprise. Com., Inc.
Purification on silica gel refers to gravity column chroma-
tography on Merck Silica Gel 60 (particle size 230-400 mesh).
Analytical TLC was performed on precoated plates purchased
from Merck (Silica Gel 60 F254). Compounds were visualized
by use of UV light, I2 vapor, or 2.5% phosphomolybdic acid in
ethanol with heating.
1
evidenced by NMR analyses. H NMR (CDCl3) δ 1.44 (s, 3H,
CCH3), 1.49 (s, 3H, CCH3), 3.72 (s, 3H, OCH3), 3.87 (s, 3H,
OCH3), 4.10 (dd, J ) 6.96, 6.57 Hz, 1H, HC(7)), 4.17 (dd, J )
6.96, 6.57 Hz, 1H, HC(7)), 5.14 (dd, J ) 6.57, 6.57 Hz, 1H,
H-C(6)); 13C NMR (CDCl3) δ 25.73, 25.92, 58.14, 61.22, 66.16,
68.99, 109.45, 122.54 (t, J ) 125.00 Hz, D-C(2)), 136.29, 138.29,
144.19; UV (EtOH): λmax 266 (ꢀ 18,000), 275 (ꢀ 16,500), 295 (ꢀ
17,600); CIMS m/z: 230 (M+ + 1), 229 (M+).
Sta n d a r d P r oced u r e for P r ep a r a tion of 2,3-Dia lk oxy-
5,6-a lk ylid en e-L-a scor bic Acid s 2a -d . A solution of 3a -d
(0.50 mmol) in CDCl3 (2.70 mL) was irradiated by a 450-W
medium-pressure Hanovia mercury lamp (λ > 250 nm) placed
inside a water cooled (15-25 °C) Pyrex immersion well.
Oxygen flow was maintained during photolysis, and the
reaction temperature was kept near 20 °C by regulating the
temperature of the water. After 3.0 h, the solvent was
concentrated under reduced pressure, and the residue was
purified by use of column chromatography (20% EtOAc in
hexanes as eluant) to give the corresponding vitamin C
derivatives 2a -d in about 75% yield. For 2a : mp 62-63 °C;
IR (KBr) 1764 (CdO), 1681 (CdC) cm-1; H NMR (CDCl3) δ
3.82 (dd, J ) 8.60, 6.60 Hz, 1H, HC(6)), 3.91 (dd, J ) 8.60,
6.60, 1H, HC(6)), 4.09-4.14 (ddd, J ) 6.60, 6.60, 2.80 Hz, 1H,
H-C(5)), 4.46 (d, J ) 2.80 Hz, 1H, H-C(4)), 4.81 (s, 2H, OCH2O),
5.02 (s, 2H, H2COC(2)), 5.09 (d, J ) 8.60 Hz, 2H, H2COC(3)),
7.09-7.28 (m, 10H, 2C6H5); 13C NMR (CDCl3) δ 65.56, 72.98,
73.45, 73.59, 74.64, 96.06, 121.04, 127.62, 128.45, 128.90,
135.13, 135.75, 156.39, 168.66; MS m/z: 368 (M+); CIMS m/z:
369 (M+ + 1), 368 (M+). Anal. Calcd for C21H20O6: C, 68.47;
H, 5.47. Found: C, 68.58; H, 5.59. For 2b: mp 91-92 °C; IR
(20) (a) Rai’c-Mali’c, S.; Hergold-Brundi’c, A.; Nagl, A.; Grdisa, M.;
Paveli’c, K.; DeClercq, E.; Mintas, M. J . Med. Chem. 1999, 42, 2673-
2678. (b) Rai’c-Mali’c, S.; Svedruzi’c, D.; Gazivoda, T.; Marunovi’c, A.;
Hergold-Brundi’c, A.; Nagl, A.; Balzarini, J .; DeClercq, E.; Mintas, M.
J . Med. Chem. 2000, 43, 4806-4811.